| Popis: |
Millions of women and their families around the world are affected by premenstrual disorders. These conditions cause significant impairment for women, resulting in emotional, somatic, and/or behavioural symptoms in the luteal phase of the menstrual cycle. Following the recent International Society for Premenstrual Disorders (ISPMD) consensus, these disorders have been divided into core and variant premenstrual disorders. Diagnosis is complex as there are no objective tests. Use of a prospective symptom scoring chart, by women, to record their daily symptoms is recommended to support a definitive diagnosis in addition to a multidisciplinary team approach for management of women with premenstrual syndrome (PMS). Treatments are broadly divided into two categories, based on ovulation suppression and neuroendocrine manipulation. These include lifestyle modifications, cognitive behaviour therapy, combined oral contraception, selective serotonin reuptake inhibitors, oestradiol, and progesterone, gonadotrophin-releasing hormone analogues and surgery (bilateral salpingo-ophorectomy and hysterectomy) as a last resort. |
